Thalidomide for myeloma: still here?

Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1016/s2352-3026(18)30154-6

Back

Shared by

Meletios A Dimopoulos

Thalidomide for myeloma: still here?

Letter 2018 en

Authors

Meletios A Dimopoulos
EK
Efstathios Kastritis

Related publications

Article2001

Thalidomide and dexamethasone combination for refractory multiple myeloma

Meletios A Dimopoulos, Konstantinos Zervas, G. Kouvatseas, Eleni Galani, Vassiliki Grigoraki, Christos Kiamouris, E. Vervessou, E. Samantas, C Papadimitriou, Olga Economou, Dimitra Gika, Panayiotis Panayiotidis, Ioannis Christakis, Nicolaos Anagnostopoulos

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Article

2007

Thalidomide in the treatment of multiple myeloma

Efstathios Kastritis, Meletios A Dimopoulos

Article2007

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

Antonio Palumbo, S. Vincent Rajkumar, Meletios A Dimopoulos, Paul G. Richardson, Jesús F. San Miguel, Bart Barlogie, Jean‐Luc Harousseau, Jeffrey A. Zonder, Michèle Cavo, Maurizio Zangari, Michel Attal, Andrew R. Belch, Stefan Knop, D. Joshua, Orhan Sezer, Heinz Ludwig, David H. Vesole, Joan Bladé, Robert A. Kyle, Jan Westin, Diane Weber, Sara Bringhen, Rubén Niesvizky, Anders Waage, Marie von Lilienfeld‐Toal, Sagar Lonial, Gareth J. Morgan, Robert Z. Orlowski, Kazuyuki Shimizu, Kenneth C. Anderson, Mario Boccadoro, Brian G.M. Durie, Pieter Sonneveld, M. A. Hussein

Letter2008

Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma

Meletios A Dimopoulos, Efstathios Kastritis

Article2001

Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma

Meletios A Dimopoulos, Panayiotis Panayiotidis, Vassiliki Grigoraki, Christos Poziopoulos, Irini Xilouri, Christos Kiamouris, Anna Tassidou, Dimitra Gika, K Stefanoudaki, Nicolaos Anagnostopoulos, Dimitra Anagnostou